Moxifloxacin Hydrochloride
10 NDCs across 9 manufacturers|9 Generic,1 Brand
Moxifloxacin Hydrochloride is used to treat bacteroides infections, bronchitis, cystitis, escherichia coli infections, gonorrhea and haemophilus infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Dec 10, 1999, and the first generic was approved Feb 18, 2014. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient.
Moxifloxacin Hydrochloride is available as 10 NDCs from 9 manufacturers (9 generic, 1 brand), with NADAC prices from $1.34 to $1.34 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
9G / 1B
Manufacturers
9
competing in market
Price Spread
$1.34 – $1.34
per EA, 6 of 10 NDCs
7d Activity
avg +1.0% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Major Pharmaceuticals manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Fluoroquinolone Antibacterial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing MOXIFLOXACIN HYDROCHLORIDE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
VIGAMOX 0.5% EYE DROPS | $31.8080 per ML | — |
MOXIFLOXACIN 0.5% EYE DROPS | $1.5963 per ML | +3.75% |
MOXIFLOXACIN 0.5% EYE DROPS | $1.5963 per ML | +3.75% |
MOXIFLOXACIN 0.5% EYE DROPS | $1.5963 per ML | +3.75% |
MOXIFLOXACIN HCL 400 MG TABLET | $1.3372 per EA | -0.42% |
MOXIFLOXACIN HCL 400 MG TABLET | $1.3372 per EA | -0.42% |
MOXIFLOXACIN HCL 400 MG TABLET | $1.3372 per EA | -0.42% |
MOXIFLOXACIN HCL 400 MG TABLET | $1.3372 per EA | -0.42% |
MOXIFLOXACIN HCL 400 MG TABLET | $1.3372 per EA | -0.42% |
MOXIFLOXACIN HCL 400 MG TABLET | $1.3372 per EA | -0.42% |
Frequently Asked Questions
What is Moxifloxacin Hydrochloride used to treat?
Moxifloxacin Hydrochloride is used to treat bacteroides infections, bronchitis, cystitis, escherichia coli infections, gonorrhea and haemophilus infections, per the National Library of Medicine's MED-RT classification.
When did Moxifloxacin Hydrochloride become available as a generic?
FDA approved the first generic Moxifloxacin Hydrochloride (ANDA) on Feb 18, 2014. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Moxifloxacin Hydrochloride products are on the market?
The Moxifloxacin Hydrochloride drug market contains 10 NDCs from 9 manufacturers — 9 generic and 1 brand product.
What is the price range for Moxifloxacin Hydrochloride?
NADAC reference prices for Moxifloxacin Hydrochloride range from $1.3372 to $1.3372 per EA. 4 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Which manufacturers make Moxifloxacin Hydrochloride?
9 manufacturers list Moxifloxacin Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Major Pharmaceuticals (2), Harrow Eye, LLC (1), Upsher-Smith Laboratories LLC (1), Sandoz Inc. (1), Somerset Therapeutics, LLC (1).
How has the price of Moxifloxacin Hydrochloride changed recently?
Over the past 7 days, 3 Moxifloxacin Hydrochloride NDCs rose and 6 fell, with a market-wide average change of +1.0%.